First Time Loading...

Jaguar Health Inc
NASDAQ:JAGX

Watchlist Manager
Jaguar Health Inc Logo
Jaguar Health Inc
NASDAQ:JAGX
Watchlist
Price: 0.2663 USD -7.12% Market Closed
Updated: May 17, 2024
Section:
 

Wall Street
Price Targets

JAGX Price Targets Summary
Jaguar Health Inc

Wall Street analysts forecast JAGX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JAGX is 0.612 USD with a low forecast of 0.606 USD and a high forecast of 0.63 USD.

JAGX Lowest Forecast
Wall Street Target
0.606 USD
128% Upside
JAGX Average Forecast
Wall Street Target
0.612 USD
130% Upside
JAGX Highest Forecast
Wall Street Target
0.63 USD
137% Upside
Lowest
Price Target
0.606 USD
128% Upside
Average
Price Target
0.612 USD
130% Upside
Highest
Price Target
0.63 USD
137% Upside
Jaguar Health Inc Competitors:
Price Targets
C
214370
Caregen Co Ltd
128% Upside
603590
Beijing Konruns Pharmaceutical Co Ltd
46% Upside
300026
Tianjin Chase Sun Pharmaceutical Co Ltd
469% Upside
600521
Zhejiang Huahai Pharmaceutical Co Ltd
4% Upside
C
214370
Caregen Co Ltd
128% Upside
603590
Beijing Konruns Pharmaceutical Co Ltd
46% Upside
300026
Tianjin Chase Sun Pharmaceutical Co Ltd
469% Upside
600521
Zhejiang Huahai Pharmaceutical Co Ltd
4% Upside
600420
Shanghai Shyndec Pharmaceutical Co Ltd
46% Upside
MYX
Mayne Pharma Group Ltd
13% Upside
A
002821
Asymchem Laboratories Tianjin Co Ltd
37% Upside
XERS
Xeris Biopharma Holdings Inc
141% Upside

Revenue
Forecast

Revenue Estimate
Jaguar Health Inc

For the last 8 years the compound annual growth rate for Jaguar Health Inc's revenue is 57%. The projected CAGR for the next 2 years is 64%.

57%
Past Growth
64%
Estimated Growth
Estimates Accuracy
-15%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Jaguar Health Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Jaguar Health Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-100%
Average Miss
What are analyst estimates?

See Also

Summary
JAGX intrinsic value, competitors valuation, and company profile.
DCF Valuation
JAGX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
JAGX stock valuation using valuation multiples.
Wall Street Estimates
JAGX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
JAGX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is JAGX's stock price target?
Price Target
0.612 USD

According to Wall Street analysts, the average 1-year price target for JAGX is 0.612 USD with a low forecast of 0.606 USD and a high forecast of 0.63 USD.

What is Jaguar Health Inc's Revenue forecast?
Projected CAGR
64%

For the last 8 years the compound annual growth rate for Jaguar Health Inc's revenue is 57%. The projected CAGR for the next 2 years is 64%.

ALPHA SPREAD
Join more than 138,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.